Skip to main content

Advertisement

Table 2 Number of people (%) with type 2 diabetes and different types of treatment, including a) non-secretagogues e.g. metformin, pioglitazone, DPP-4 inhibitor, SGLT-2 inhibitor, GLP-1 agonist; b) secretagogues e.g. sulfonylureas and glinides; and insulin treated type 2 diabetes

From: Temporal changes in frequency of severe hypoglycemia treated by emergency medical services in types 1 and 2 diabetes: a population-based data-linkage cohort study

Group of people with type 2 diabetes Number of people (%) Proportion difference (95% CI) P value
June 1997 – May 1998 (n = 7678) 1 Jan 2011–31 Dec 2012 (n = 21,734)
a) 3954 (51.5%) 12,812 (58.9%) 0.075 (0.062–0.087) < 0.001
b) 2823 (36.8%) 4859 (22.4%) −0.144 (−0.156 – −0.132) < 0.001
Insulin 901 (11.7%) 4063 (18.7%) 0.070 (0.061–0.078) < 0.001